Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

99.76 +0.87 (+0.88%)
Official Closing Price Updated: 8:00 PM EDT, Jul 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,722,169
Open 98.56
Bid (Size) 99.53 (12)
Ask (Size) 99.71 (30)
Prev. Close 98.89
Today's Range 98.26 - 100.25
52wk Range 63.80 - 103.52
Shares Outstanding 778,000
Dividend Yield 0.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Dow, The Russell, And The Biotech Sector Are Storming Higher
The Dow Jones Industrials have come up 4.2% over the latest five-day, while the Russell 2000 index of U.S. small-caps is up nearly 11% - it’s having its best week in 24 years. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Bearish Shooting Star Shines
Following signs of resistance in biotech ETF XBI on Friday, a shooting star forms. A bearish retracement may take hold soon.. 
Via Talk Markets
Topics ETFs

Performance

YTD
+10.56%
+10.56%
1 Month
+6.42%
+6.42%
3 Month
+17.79%
+17.79%
6 Month
+11.80%
+11.80%
1 Year
+19.59%
+19.59%

More News

Read More
AskSlim Market Week - Friday, July 12
Via Talk Markets
Stocks Are Breaking Down Beneath The Surface
Via Talk Markets
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Via Talk Markets
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Via Benzinga
Topics ETFs
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Via Benzinga
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
Via Benzinga
Topics Economy
Exposures Interest Rates
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
Via Talk Markets
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
Via InvestorPlace
American Express, Trade Desk And More: CNBC's 'Final Trades'
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
Via InvestorPlace
Should I Be Worried? Stock Market (And Sentiment Results)…
Via Talk Markets
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
Via InvestorPlace
Exposures Product Safety
Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks
Via InvestorPlace
For Biotech Stocks To Move Higher, This Must Move Lower
Via Talk Markets
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
AskSlim Market Week - Friday, April 26
Via Talk Markets
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
Via InvestorPlace
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
Via Talk Markets
Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns
Via Benzinga
Topics Economy
Exposures Interest Rates
5 Healthcare Stocks to Buy for 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Healthcare And Biotech Stocks Review: Q1 2024 Performance
Via Talk Markets
Topics Stocks
Exposures US Equities
2 Top Biotech Buyout Candidates
Via Talk Markets
3 Top ETFs I Plan to Buy in April
Via The Motley Fool
Topics ETFs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.